NSPR - InspireMD, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue3,6012,7611,8942,310
Cost of Revenue2,6062,1761,7922,606
Gross Profit995585102-296
Operating Expenses
Research Development1,5351,2761,2913,642
Selling General and Administrative7,0717,5416,4599,565
Non Recurring----
Others----
Total Operating Expenses11,21210,9939,54215,813
Operating Income or Loss-7,611-8,232-7,648-13,503
Income from Continuing Operations
Total Other Income/Expenses Net371-179-812-2,078
Earnings Before Interest and Taxes-7,611-8,232-7,648-13,503
Interest Expense--119-721-1,036
Income Before Tax-7,240-8,411-8,460-15,581
Income Tax Expense-2714
Minority Interest----
Net Income From Continuing Ops-7,240-8,438-8,461-15,585
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-7,240-8,438-8,461-15,585
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-7,696-13,028-8,461-15,585